Stay updated on Phase II Pembrolizumab Plus GVD Clinical Trial

Sign up to get notified when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Pembrolizumab Plus GVD Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page's revision marker was bumped from v3.6.5 to v3.6.6, indicating a maintenance/metadata update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-30T22:30:35.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s revision history now includes a new entry for v3.6.5 dated 2026-08-07, along with prior August revisions; this indicates an update to the page’s revision history and timestamps.
    Difference
    0.2%
    Check dated 2026-08-09T11:00:38.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, signaling a routine deployment or patch. No study details or user-facing content appears to be altered.
    Difference
    0.0%
    Check dated 2026-07-25T17:52:51.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    ISRT sections were added (PART 3A/3B) with reference to ISRT guidelines for nodal disease. Eligibility criteria were updated to specify PET-based Lugano measurable disease and autoimmune disease exclusions, and the study endpoints include a 5-year disease-free survival assessment.
    Difference
    1%
    Check dated 2026-07-18T15:43:22.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page metadata was updated to reflect a new revision (v3.6.3) and more recent update dates (2026-06-26 and 2026-06-29), indicating an administrative update to the study record.
    Difference
    0.2%
    Check dated 2026-07-04T13:19:10.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a software update to the page. No changes to the displayed study details or layout are evident from this revision.
    Difference
    0.0%
    Check dated 2026-06-27T06:40:14.000Z thumbnail image

Stay in the know with updates to Phase II Pembrolizumab Plus GVD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.